Fortis Healthcare: Final Dividend of ₹1 Per Share Recommended; AGM on Aug 11
Fortis Healthcare recommended a final dividend of ₹1 per equity share for FY26. The 30th AGM is scheduled for August 11, 2026, to approve the dividend. The record date is July 24, 2026. Shareholders must update details and submit TDS-related declarations by August 5, 2026.
The dividend announcement and the associated AGM date are material information for shareholders. The detailed guidance on TDS implications and deadlines also requires shareholder attention, impacting their administrative actions.
The announcement is a standard intimation regarding dividend recommendation, AGM details, and TDS procedures. While the dividend itself is a positive indicator, the primary focus is on the procedural aspects of tax deduction, making the overall sentiment neutral.
Fortis Healthcare Limited has announced that its Board of Directors, in a meeting held on May 22, 2026, recommended a final dividend of ₹1 per equity share for the financial year ended March 31, 2026. This recommendation is subject to the approval of the shareholders at the 30th Annual General Meeting (AGM), which is scheduled to be held on August 11, 2026.
The dividend, if declared at the AGM, will be subject to Tax Deduction at Source (TDS) as per the provisions of the Income Tax Act, 2025, and the Income Tax Rules, 2026. The company will deduct tax based on shareholder information provided by depositories and its Register of Members. The record date for determining shareholder entitlement for the dividend payment has been fixed as Friday, July 24, 2026.
Shareholders are urged to ensure their details such as PAN, residential status, category, bank account details, email, and postal address are updated. Those seeking exemption or lower tax deduction must submit necessary declarations and supporting documents by August 5, 2026, through the provided weblink or email. Detailed procedures and requirements for both resident and non-resident shareholders, including specific forms and documentation for availing Double Tax Avoidance Agreement (DTAA) benefits, have been outlined. The company also reminded shareholders about the mandatory linking of PAN with Aadhaar to avoid higher TDS rates.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.